Clinical Trial

A Phase II Exploratory Clinical Trial of Multiple Drug Combinations in the Treatment of Advanced Esophageal Squamous Cell Carcinoma

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to observe and evaluate the efficacy and safety of multiple drug combinations in the treatment of advanced esophageal squamous cell carcinoma.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2018-11-08; most recent amendment 2024-09-12.
Status change: Not Yet Recruiting → Recruiting 2020-09-28
Trial Details
NCT Number NCT03736863
Lead Sponsor The First Affiliated Hospital of Zhengzhou University
Conditions Esophageal Cancer
Enrollment 147 participants
Start Date 2019-12-05
Primary Completion 2021-06-20 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-09-19